(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Lupus Nephritis pipeline constitutes 20+ key companies continuously working towards developing 25+ Lupus Nephritis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
“Lupus Nephritis Pipeline Insight, 2023“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Lupus Nephritis Market.
The Lupus Nephritis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Lupus Nephritis Pipeline Report:
- Companies across the globe are diligently working toward developing novel Lupus Nephritis treatment therapies with a considerable amount of success over the years.
- Lupus Nephritis companies working in the treatment market are Inflection Biosciences, Roche, Equillium, BeiGene, Janssen Research & Development, Horizon Therapeutics, Novartis, Roche, AstraZeneca, Novartis, Alexion Pharmaceuticals, AstraZeneca, Equillium, and others, are developing therapies for the Lupus Nephritis treatment
- Emerging Lupus Nephritis therapies in the different phases of clinical trials are- IBL-101, RG 6107, Itolizumab, Zanubrutinib, Guselkumab, Daxdilimab, Secukinumab, Obinutuzumab, GAZYVA, Saphnelo (Anifrolumab), Iscalimab, Cosentyx, Ravulizumab, Anifrolumab, Itolizumab, and others are expected to have a significant impact on the Lupus Nephritis market in the coming years.
- In July 2023, Kyverna Therapeutics (“Kyverna”), a cell therapy company with the goal of creating a new class of treatments for severe autoimmune diseases, announced today that the Paul-Ehrlich-Institut (PEI) in Germany has approved its first Clinical Trial Application (CTA) for KYV101, a cutting-edge therapy for the treatment of lupus nephritis (LN). In order to treat autoimmune disorders caused by B cells, such as LN, KYV-101 is a unique, totally human anti-CD19 CAR T-cell therapy. It provides a ground-breaking strategy for battling autoimmune diseases by utilising the body’s immune system
Lupus Nephritis Overview
One of the most serious organ symptoms of systemic lupus erythematosus (SLE), an autoimmune disease that results in the loss of immunological tolerance to endogenous nuclear material and systemic autoimmunity, is lupus nephritis (LN).
Get a Free Sample PDF Report to know more about Lupus Nephritis Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/lupus-nephritis-pipeline-insight
Emerging Lupus Nephritis Drugs Under Different Phases of Clinical Development Include:
- IBL-101: Inflection Biosciences
- RG 6107: Roche
- Itolizumab: Equillium
- Zanubrutinib: BeiGene
- Guselkumab: Janssen Research & Development
- Daxdilimab: Horizon Therapeutics
- Secukinumab: Novartis
- Obinutuzumab: Roche
- GAZYVA: Roche
- Saphnelo (Anifrolumab): AstraZeneca
- Iscalimab: Novartis
- Cosentyx: Novartis
- Ravulizumab: Alexion Pharmaceuticals
- Anifrolumab: AstraZeneca
Lupus Nephritis Route of Administration
Lupus Nephritis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
- Oral
- Parenteral
- Intravenous
- Subcutaneous
- Topical
Lupus Nephritis Molecule Type
Lupus Nephritis Products have been categorized under various Molecule types, such as
- Monoclonal Antibody
- Peptides
- Polymer
- Small molecule
- Gene therapy
Lupus Nephritis Pipeline Therapeutics Assessment
- Lupus Nephritis Assessment by Product Type
- Lupus Nephritis By Stage and Product Type
- Lupus Nephritis Assessment by Route of Administration
- Lupus Nephritis By Stage and Route of Administration
- Lupus Nephritis Assessment by Molecule Type
- Lupus Nephritis by Stage and Molecule Type
DelveInsight’s Lupus Nephritis Report covers around 25+ products under different phases of clinical development like
- Late-stage products (Phase III)
- Mid-stage products (Phase II)
- Early-stage product (Phase I)
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates
- Route of Administration
Further Lupus Nephritis product details are provided in the report. Download the Lupus Nephritis pipeline report to learn more about the emerging Lupus Nephritis therapies
Some of the key companies in the Lupus Nephritis Therapeutics Market include:
Key companies developing therapies for Lupus Nephritis are – Aurinia Pharmaceuticals, Roche, AstraZeneca, Boehringer Ingelheim, Novartis, Novartis Pharmaceuticals, Hoffmann-La Roche, Janssen Research & Development, BeiGene, Suzhou Suncadia Biopharmaceuticals Co., Ltd., Alexion Pharmaceuticals, Omeros Corporation, Corestem, Inc., Bristol-Myers Squibb, Boehringer Ingelheim, Apellis Pharmaceuticals, AstraZeneca, Kezar Life Sciences, Equillium, Eledon Pharmaceuticals, Resolve Therapeutics, and others.
Lupus Nephritis Pipeline Analysis:
The Lupus Nephritis pipeline report provides insights into
- The report provides detailed insights about companies that are developing therapies for the treatment of Lupus Nephritis with aggregate therapies developed by each company for the same.
- It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Lupus Nephritis Treatment.
- Lupus Nephritis key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
- Lupus Nephritis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
- Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Lupus Nephritis market.
The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Lupus Nephritis drugs and therapies
Lupus Nephritis Pipeline Market Drivers
- Increasing Prevalence of Lupus Nephritis, increase in research and developmental activities are some of the important factors that are fueling the Lupus Nephritis Market.
Lupus Nephritis Pipeline Market Barriers
- However, high-cost associated with the disease, lack of awareness among the patients about the disease and other factors are creating obstacles in the Lupus Nephritis Market growth.
Scope of Lupus Nephritis Pipeline Drug Insight
- Coverage: Global
- Key Lupus Nephritis Companies: , and others
- Key Lupus Nephritis Therapies: IBL-101, RG 6107, Itolizumab, Zanubrutinib, Guselkumab, Daxdilimab, Secukinumab, Obinutuzumab, GAZYVA, Saphnelo (Anifrolumab), Iscalimab, Cosentyx, Ravulizumab, Anifrolumab, Itolizumab, and others
- Lupus Nephritis Therapeutic Assessment: Lupus Nephritis current marketed and Lupus Nephritis emerging therapies
- Lupus Nephritis Market Dynamics: Lupus Nephritis market drivers and Lupus Nephritis market barriers
Request for Sample PDF Report for Lupus Nephritis Pipeline Assessment and clinical trials
Table of Contents
- Lupus Nephritis Report Introduction
- Lupus Nephritis Executive Summary
- Lupus Nephritis Overview
- Lupus Nephritis- Analytical Perspective In-depth Commercial Assessment
- Lupus Nephritis Pipeline Therapeutics
- Lupus Nephritis Late Stage Products (Phase II/III)
- Lupus Nephritis Mid Stage Products (Phase II)
- Lupus Nephritis Early Stage Products (Phase I)
- Lupus Nephritis Preclinical Stage Products
- Lupus Nephritis Therapeutics Assessment
- Lupus Nephritis Inactive Products
- Company-University Collaborations (Licensing/Partnering) Analysis
- Lupus Nephritis Key Companies
- Lupus Nephritis Key Products
- Lupus Nephritis Unmet Needs
- 16 . Lupus Nephritis Market Drivers and Barriers
- Lupus Nephritis Future Perspectives and Conclusion
- Lupus Nephritis Analyst Views
- Appendix
- About DelveInsight
Related Reports:
Lupus Nephritis Market
DelveInsight’s ‘Lupus Nephritis Market Insights, Epidemiology, and Market Forecast—2032’ report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
Lupus Nephritis Epidemiology
DelveInsight’s ‘Lupus Nephritis Epidemiology Forecast to 2032‘ report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports:
DelveInsight’s “Hypertrophic Scar Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Hypertrophic Scar, historical and forecasted epidemiology as well as the Hypertrophic Scar market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
DelveInsight’s “Lung Fibrosis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Lung Fibrosis, historical and forecasted epidemiology as well as the Lung Fibrosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
DelveInsight’s “Anterior Uveitis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Anterior Uveitis, historical and forecasted epidemiology as well as the Anterior Uveitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
22q11.2 deletion syndrome Market
DelveInsight’s “22q11.2 Deletion Syndrome Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the 22q11.2 Deletion Syndrome, historical and forecasted epidemiology as well as the 22q11.2 Deletion Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
X-Linked Retinitis Pigmentosa (XLRP) Market
DelveInsight’s “X-Linked Retinitis Pigmentosa Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the X-Linked Retinitis Pigmentosa (XLRP), historical and forecasted epidemiology as well as the X-Linked Retinitis Pigmentosa market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
DelveInsight’s “Scedosporium Infection Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Scedosporium Infection, historical and forecasted epidemiology as well as the Scedosporium Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2027 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2027 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.
Vein Illumination Devices Market
DelveInsight’s “Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2027” report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
DelveInsight’s “Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2027” report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Trending Reports:
Leber’s Hereditary Optic Neuropathy Market | Asmd Market | Adamantinoma Market | Acrocallosal Syndrome Market | Radiation Toxicity Market | Thymic Carcinoma Market | Hearing Aid Devices Market | Human Papilomavirus Market | Alopecia Market | Alzheimer Disease Market | Aortic Aneurysm Stent Grafts Market | Age-related Macular Degeneration Market | Blood Gas And Electrolyte Analyzers Market | Pruritus Market | Anaphylaxis Market | Hyperhidrosis Market | Neurovascular Thrombectomy Devices Market | Anemia In Ckd Market | Critical Limb Ischemia Market | Adult Growth Hormone Deficiency Market | Hepatitis B Virus Market | Allergic Conjunctivitis Market | Aesthetic Implants Market | Contraceptive Devices Market | Apheresis Market | Helicobacter Pylori Infection Market | Hemodynamic Monitoring Systems Market | Carcinoid Tumor Market | Cardiotoxicity Market | Chronic Gout Market | Central Venous Catheters Market | Cluster Headache Market | Intracranial Pressure Monitoring Devices Market | Corneal Endothelial Dystrophy Market | Urolithiasis Market | Chronic Bronchitis Market | Pain Management Devices Market | Cardiac Amyloidosis Market | Metastatic Bone Pain Market | Pediatric Obesity Market | Biochips Market | Chronic Lymphocytic Leukemia Cll Market | Chronic Lymphocytic Leukemia Market | Epilepsy Market | Catheter-related Bloodstream Infections Market | Acute Lung Injury Market | Neurotrophic Keratitis Market | Anal Cancer Market | Chronic Myelogenous Leukemia Market | Clostridium Difficile Infections Cdi Market | Alopecia Areata Market | Brain/cranial Implants Market | Pulse Oximeters Market | Surgical Stapling Devices Market | Hearing Implants Market | Bone Densitometers Market | Binge Eating Disorder Market | Chronic Inflammatory Demyelinating Polyneuropathy Market | Acute Coronary Syndrome Market | Acute Pancreatitis Market | Vertigo Market | Continuous Renal Replacement Therapy Machines Market | Brain Aneurysm Stents Market | Prader-willi Syndrome Market | Neuromodulation Devices Market | Ventricular Fibrillation Market | Dermal Erythema Market | Spinal Stenosis Market | Epidermolysis Bullosa Market | Treatment Resistant Depression Market | Chronic Insomnia Market | Colorectal Cancer Crc Market | Idiopathic Membranous Nephropathy Market | Diabetic Foot Ulcers Dfus Market | Chronic Rhinosinustis Market | Biliary Atresia Market | Choroidal Neovascularization Market | Cipn Market | Alagille Syndrome Market | Chronic Plaque Psoriasis Market | Alpha-mannosidosis Market | Becker Muscular Dystrophy Market | Opioid Induced Constipation Market | Ophthalmic Imaging Equipment Market | Hyperuricemia Market | West Syndrome Market | Chondrosarcoma Market | Hepatic Encephalopathy Epidemiology Forecast | Ventricular Hypertrophy Market | Dysthymia Market | Acute Radiation Syndrome Market | Athelete’s Foot Market | Ventricular Dysfunction Market
To know more about our Consulting Services, Click here: DelveInsight Healthcare Consulting
Recent Blog’s By DelveInsight:
- Insights Into The Cutaneous T-cell Lymphoma Treatment Market
- Roche’s HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
- Emerging Role of Digital Health in the Field of Oncology
- How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
- How are Technological Trends and Innovations Reshaping the Dementia Care
- Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
- Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
- Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
- Evaluating the Key Trends and Technologies Shaping the Future of Dentistry
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187